The Bloomberg US Aggregate Bond Index returned 1.10% during Q4, bringing YTD performance for the index to 7.30%, the best ...
Plus Therapeutics (PSTV) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.67 per share a year ago. These figures ...
IT solutions provider ePlus (NASDAQ:PLUS) reported Q4 CY2025 results , with sales up 20.3% year on year to $614.8 million. Its non-GAAP profit of $1.45 per share was 43.6% above analysts’ consensus ...
Healthcare earnings season is offering a mixed picture of the industry.  | On this week’s "Podnosis," the Fierce Healthcare team breaks down what the latest earnings reveal about the industry’s ...
Plus Therapeutics, Inc. (PSTV) on Thursday reported a loss of $5.7 million in its fourth quarter. On a per-share basis, the Houston-based company said it had a loss ...